Discovering therapeutic antibodies designed by nature


Strategic partnership with Cosmo Pharmaceuticals

December 19, 2012 - AIMM Therapeutics in strategic partnership with Cosmo Pharmaceuticals
 to combine Cosmo’s extended release technology & AIMM’s high quality antibodies to successfully combat gastrointestinal disease.

New CEO and VP Business Development

November 8, 2012 - AIMM Therapeutics appoints former head Novartis Research Institutes Jan de Vries CEO, and John Womelsdorf VP Business Development

BIO International Convention, Boston

June 15, 2012 - AIMM to present at 2012 BIO International Convention, Boston June, 2012 AIMM will present at the 2012 Bio International Convention in Boston, June 18-21.

Science webinar online

March 23, 2012 - Watch the Science webinar ‘New Approaches for Clonal Selection’ on the Science website.

BIO-Europe Spring 2012

March 13, 2012 - AIMM Therapeutics presents at the BIO-Europe Spring 2012 meeting in Amsterdam.

AIMM to present at Science webinar

March 1, 2012 - AIMM Therapeutics is invited to present in a Science webinar on Wednesday March 21.